268 related articles for article (PubMed ID: 37569811)
1. Role of Neurotrophins in Orofacial Pain Modulation: A Review of the Latest Discoveries.
Bonomini F; Favero G; Castrezzati S; Borsani E
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569811
[TBL] [Abstract][Full Text] [Related]
2. Trigeminal ganglion itself can be a viable target to manage trigeminal neuralgia.
Kc E; Islam J; Park YS
J Headache Pain; 2022 Nov; 23(1):150. PubMed ID: 36424545
[TBL] [Abstract][Full Text] [Related]
3. Potential Molecular Targets for Treating Neuropathic Orofacial Pain Based on Current Findings in Animal Models.
Nagakura Y; Nagaoka S; Kurose T
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203854
[TBL] [Abstract][Full Text] [Related]
4. Plastic changes in nociceptive pathways contributing to persistent orofacial pain.
Shinoda M; Hitomi S; Iwata K; Hayashi Y
J Oral Biosci; 2022 Sep; 64(3):263-270. PubMed ID: 35840073
[TBL] [Abstract][Full Text] [Related]
5. Orofacial neuropathic pain induced by oxaliplatin: downregulation of KCNQ2 channels in V2 trigeminal ganglion neurons and treatment by the KCNQ2 channel potentiator retigabine.
Ling J; Erol F; Viatchenko-Karpinski V; Kanda H; Gu JG
Mol Pain; 2017; 13():1744806917724715. PubMed ID: 28741430
[TBL] [Abstract][Full Text] [Related]
6. Anti-nociceptive effects of ECa 233 a standardized extract of Centella asiatica (L.) Urban on chronic neuropathic orofacial pain in mice.
Buapratoom A; Wanasuntronwong A; Khongsombat O; Tantisira MH
J Ethnopharmacol; 2022 Jan; 283():114737. PubMed ID: 34648902
[TBL] [Abstract][Full Text] [Related]
7. A potent and selective calcitonin gene-related peptide (CGRP) receptor antagonist, MK-8825, inhibits responses to nociceptive trigeminal activation: Role of CGRP in orofacial pain.
Romero-Reyes M; Pardi V; Akerman S
Exp Neurol; 2015 Sep; 271():95-103. PubMed ID: 25981890
[TBL] [Abstract][Full Text] [Related]
8. Use of Botulinum Toxin in Orofacial Clinical Practice.
Serrera-Figallo MA; Ruiz-de-León-Hernández G; Torres-Lagares D; Castro-Araya A; Torres-Ferrerosa O; Hernández-Pacheco E; Gutierrez-Perez JL
Toxins (Basel); 2020 Feb; 12(2):. PubMed ID: 32053883
[TBL] [Abstract][Full Text] [Related]
9. Implication of the chemokine CCL2 in trigeminal nociception and traumatic neuropathic orofacial pain.
Dauvergne C; Molet J; Reaux-Le Goazigo A; Mauborgne A; Mélik-Parsadaniantz S; Boucher Y; Pohl M
Eur J Pain; 2014 Mar; 18(3):360-75. PubMed ID: 23918315
[TBL] [Abstract][Full Text] [Related]
10. Peripheral Purinergic Modulation in Pediatric Orofacial Inflammatory Pain Affects Brainstem Nitroxidergic System: A Translational Research.
Borsani E; Ballini A; Buffoli B; Muzio LL; Di Domenico M; Boccellino M; Scacco S; Nocini R; Dibello V; Rezzani R; Cantore S; Rodella LF; Cosola MD
Biomed Res Int; 2022; 2022():1326885. PubMed ID: 35309172
[TBL] [Abstract][Full Text] [Related]
11. Neurotrophin receptor expression is induced in a subpopulation of trigeminal neurons that label by retrograde transport of NGF or fluoro-gold following tooth injury.
Wheeler EF; Naftel JP; Pan M; von Bartheld CS; Byers MR
Brain Res Mol Brain Res; 1998 Oct; 61(1-2):23-38. PubMed ID: 9795112
[TBL] [Abstract][Full Text] [Related]
12. Intraganglionar resiniferatoxin prevents orofacial inflammatory and neuropathic hyperalgesia.
Cruz LS; Kopruszinski CM; Chichorro JG
Behav Pharmacol; 2014 Apr; 25(2):112-8. PubMed ID: 24557321
[TBL] [Abstract][Full Text] [Related]
13. Is Botulinum Toxin Effective in Treating Orofacial Neuropathic Pain Disorders? A Systematic Review.
Val M; Delcanho R; Ferrari M; Guarda Nardini L; Manfredini D
Toxins (Basel); 2023 Sep; 15(9):. PubMed ID: 37755967
[TBL] [Abstract][Full Text] [Related]
14. P2X
Koizumi M; Asano S; Furukawa A; Hayashi Y; Hitomi S; Shibuta I; Hayashi K; Kato F; Iwata K; Shinoda M
J Headache Pain; 2021 Apr; 22(1):31. PubMed ID: 33902429
[TBL] [Abstract][Full Text] [Related]
15. Neurotrophins and Neuropathic Pain: Role in Pathobiology.
Khan N; Smith MT
Molecules; 2015 Jun; 20(6):10657-88. PubMed ID: 26065639
[TBL] [Abstract][Full Text] [Related]
16. (-)-α-Bisabolol reduces nociception and trigeminal central sensitisation in acute orofacial neuropathic pain induced by infraorbital nerve injury.
Melo LT; Panchalingam V; Cherkas P; Campos AR; Avivi-Arber L; Sessle BJ
Life Sci; 2019 Jun; 227():122-128. PubMed ID: 31002923
[TBL] [Abstract][Full Text] [Related]
17. Activation of oxytocin receptor in the trigeminal ganglion attenuates orofacial ectopic pain attributed to inferior alveolar nerve injury.
Huang CL; Liu F; Zhang YY; Lin J; Fu M; Li YL; Zhou C; Li CJ; Shen JF
J Neurophysiol; 2021 Jan; 125(1):223-231. PubMed ID: 33326336
[TBL] [Abstract][Full Text] [Related]
18. Developmental changes in the response of trigeminal neurons to neurotrophins: influence of birthdate and the ganglion environment.
Enokido Y; Wyatt S; Davies AM
Development; 1999 Oct; 126(19):4365-73. PubMed ID: 10477303
[TBL] [Abstract][Full Text] [Related]
19. Calcium channel α2δ1 proteins mediate trigeminal neuropathic pain states associated with aberrant excitatory synaptogenesis.
Li KW; Yu YP; Zhou C; Kim DS; Lin B; Sharp K; Steward O; Luo ZD
J Biol Chem; 2014 Mar; 289(10):7025-7037. PubMed ID: 24459143
[TBL] [Abstract][Full Text] [Related]
20. The role of satellite glial cells in orofacial pain.
Fan W; Zhu X; He Y; Zhu M; Wu Z; Huang F; He H
J Neurosci Res; 2019 Apr; 97(4):393-401. PubMed ID: 30450738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
